One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-145723
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 5 |
Affiliation: University Hospital Leipzig, University of Florence, Moffitt Cancer Center, Yale Cancer Center, The University of Texas MD Anderson Cancer Center, Health Sciences Centre, Sunnybrook Health Science Centre, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Switzerland), Bristol-Myers Squibb (Italy), Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Université Paris CitéAnalysis of Duration of Response, Exposure-Adjusted Safety and Progression to Acute Myeloid Leukemia (AML) for Patients with Lower-Risk Myelodysplastic Syndromes (LR-MDS) Receiving Luspatercept in the MEDALIST Study
Sign-in/Register to access full text options 
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
